Skip to content
TriangleGet started
← Gastrointestinal Stromal Tumors

FOR PATIENTS · SOURCE READING

Treatment of Refractory Gastrointestinal Stromal Tumors

Source: Gastrointestinal Stromal Tumors Treatment (Adult) (PDQ®)–Patient Version, National Cancer Institute.

Source updated: August 28, 2020 · Captured 2026-09-09.

Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.

For information about the treatments listed below, see the Treatment Option Overview section.

Source links and citations

Many GISTs treated with a tyrosine kinase inhibitor (TKI) become refractory (stop responding) to the drug after a while. Treatment is usually a clinical trial with a different TKI or a clinical trial of a new drug.

Source links and citations

Preserved source evidence · Independent clinical review pending · Not medical advice